Bleeding risk with dabigatran, rivaroxaban, warfarin, and antiplatelet agent in Asians with non-valvular atrial fibrillation. [electronic resource]
Publication details: Oncotarget Nov 2017Description: 98898-98917 p. digitalISSN:- 1949-2553
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.